Our Pricing

Get Your Weight Loss Injection Prescription Online UK

Published on: June 03, 2026

Getting a weight loss injection prescription online UK service has transformed access to clinically proven treatments like Mounjaro, Wegovy, and Saxenda. At Cured Pharmacy, our UK-registered clinical team provides free online consultations in under 3 minutes, with transparent upfront pricing and discreet next-day delivery across the UK.

How Weight Loss Injection Prescription Online UK Services Work

Weight loss injections available through UK online pharmacies belong to a class of medications called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and blood sugar levels [1]. These prescription-only medicines require clinical assessment by a UK-registered prescriber before dispensing, ensuring they're safe and appropriate for your individual health profile.

The online consultation process at Cured Pharmacy takes under 3 minutes and involves completing a comprehensive medical questionnaire reviewed by our UK clinical team. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure compliance with MHRA and GPhC standards. If approved, your medication is dispensed from our UK-registered pharmacy (GPhC 9012511) and delivered discreetly to your door.

All weight loss injections require ongoing clinical monitoring. Your prescriber will determine the appropriate starting dose and titration schedule based on your medical history, current medications, and weight loss goals. Regular follow-up consultations ensure the treatment remains safe and effective throughout your weight management programme.

Mounjaro Weight Loss Injections: The Dual-Action Treatment

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for weight management [2]. Unlike single-pathway treatments, tirzepatide activates two complementary hormone systems that regulate appetite, food intake, and energy expenditure, producing superior clinical outcomes in head-to-head trials.

In the SURMOUNT-1 trial, participants receiving the highest tirzepatide dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than results seen with semaglutide-based alternatives [2]. The treatment works by reducing hunger signals, increasing feelings of fullness after meals, and slowing gastric emptying to prolong satiety.

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. Treatment begins at a lower dose to minimise gastrointestinal side effects, with gradual increases every 4 weeks until reaching the optimal maintenance dose determined by your prescriber. At Cured Pharmacy, Mounjaro starts from £135.00, with pricing confirmed before your consultation begins.

Who Can Use Mounjaro?

Mounjaro is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Your UK prescriber will assess your eligibility during the online consultation, reviewing your medical history, current medications, and any contraindications before approving treatment.

Wegovy and Saxenda: Proven Semaglutide and Liraglutide Options

Wegovy contains semaglutide, a GLP-1 receptor agonist that has been extensively studied in the STEP clinical trial programme. In STEP 1, participants achieved an average weight reduction of 14.9% over 68 weeks, with two-thirds of patients losing at least 10% of their baseline body weight [4]. Wegovy is administered once weekly and follows a structured dose escalation schedule to optimise tolerability.

Saxenda contains liraglutide, a daily injectable GLP-1 treatment that has been available in the UK since 2015. The SCALE trial programme demonstrated an average weight loss of 8% over 56 weeks in participants using liraglutide alongside lifestyle modifications [5]. While requiring daily administration compared to weekly alternatives, Saxenda offers a lower entry price point and may suit patients preferring more frequent dosing adjustments.

Both medications work by mimicking the GLP-1 hormone, which reduces appetite, increases satiety, and helps regulate blood glucose levels. Your UK prescriber will recommend the most appropriate treatment based on your medical history, lifestyle preferences, budget considerations, and previous response to weight management interventions.

Choosing Between Injectable Options

The choice between Mounjaro, Wegovy, and Saxenda depends on multiple factors including efficacy targets, dosing frequency preferences, side effect profiles, and cost considerations. Clinical trials suggest tirzepatide produces the greatest average weight reduction, followed by semaglutide and liraglutide [2][4][5]. However, individual responses vary, and some patients may achieve better results or tolerability with one treatment over another. Your prescriber will discuss these options during your consultation to identify the optimal choice for your circumstances.

Orlistat and Oral Weight Loss Medications

Orlistat represents a different mechanism of action compared to GLP-1 injections, working by blocking the absorption of approximately 30% of dietary fat in the digestive system [6]. Available in 120mg prescription strength (Xenical, generic orlistat) and 60mg over-the-counter formulations (Alli, Orlos), orlistat may suit patients who prefer oral medications or have contraindications to injectable treatments.

Clinical trials demonstrate that orlistat combined with a reduced-calorie diet produces an average additional weight loss of 2-3kg compared to diet alone over 12 months [6]. The medication requires three daily doses taken with meals containing fat, and works best when combined with a structured eating plan limiting fat intake to approximately 30% of total calories.

Side effects of orlistat are primarily gastrointestinal and can include oily stools, increased bowel movements, and faecal urgency, particularly when consuming high-fat meals. These effects often diminish as patients adapt their dietary habits. Orlistat may be appropriate for patients seeking a non-systemic treatment option or those unable to use GLP-1 medications due to medical contraindications.

What to Expect During Your Weight Loss Injection Prescription Online UK Consultation

The online consultation process begins with a comprehensive medical questionnaire covering your weight history, previous weight loss attempts, current medications, and relevant medical conditions. This information allows our UK prescribers to assess your suitability for weight loss injections and identify any contraindications or drug interactions that may affect treatment safety.

Your prescriber will review your BMI calculation, weight-related health conditions, and treatment goals to determine the most appropriate medication and starting dose. For injectable treatments, you'll receive detailed instructions on proper injection technique, pen device operation, storage requirements, and dose escalation schedules. Our clinical team remains available throughout your treatment for questions or concerns about side effects or progress.

Follow-up consultations are typically scheduled every 4-12 weeks depending on your chosen medication and response to treatment. These reviews allow your prescriber to monitor weight loss progress, assess tolerability, adjust dosing if needed, and provide ongoing support for lifestyle modifications. All consultations at Cured Pharmacy are provided free of charge, with transparent pricing shown upfront before you begin the assessment.

Prescription Approval and Delivery

If your consultation is approved, your prescription is sent to our UK-registered pharmacy for dispensing. We source only genuine UK-licensed medications from authorised wholesalers, ensuring product authenticity and quality. Orders are packaged discreetly with no external markings indicating contents, and delivered via tracked courier services offering next-day delivery across most UK postcodes. Temperature-sensitive medications like weight loss injections are shipped in insulated packaging with ice packs to maintain proper storage conditions during transit.

Managing Side Effects and Maximising Results

The most common side effects of GLP-1 weight loss injections are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation [1][4][5]. These effects typically occur during initial treatment or dose escalation phases and usually diminish within 4-8 weeks as your body adapts to the medication. Starting at lower doses and following the prescribed titration schedule significantly reduces the severity of these symptoms.

To minimise gastrointestinal side effects, eat smaller, more frequent meals rather than large portions, avoid high-fat and spicy foods, stay well-hydrated, and take your injection on the same day each week at a consistent time. If nausea occurs, ginger tea, bland foods, and eating slowly may provide relief. Persistent or severe side effects should be reported to your prescriber, who may adjust your dose or recommend additional management strategies.

Weight loss injections work most effectively when combined with sustainable lifestyle modifications including a balanced, reduced-calorie diet and regular physical activity. Clinical trials demonstrating the impressive efficacy of these medications included participants following structured nutrition and exercise programmes [2][4][5]. Your prescriber can provide guidance on appropriate calorie targets, macronutrient distribution, and activity recommendations tailored to your individual circumstances and weight loss goals.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/ [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity [TA1003]. NICE. https://www.nice.org.uk/guidance/ta1003 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.